Bank of China A-share price in focus: 601988 faces Monday policy test as leverage rules tighten
18 January 2026
2 mins read

Bank of China A-share price in focus: 601988 faces Monday policy test as leverage rules tighten

SHANGHAI, Jan 19, 2026, 05:18 CST — Premarket

  • Bank of China’s A shares on the Shanghai exchange last traded at 5.40 yuan, slipping 0.55%.
  • China’s central bank will implement rate adjustments alongside stricter margin-financing rules starting Jan. 19.
  • Investors are also watching the monthly Loan Prime Rate announcement expected around Jan. 20.

Bank of China Ltd’s A shares (601988) are set to open Monday under the influence of policy moves, having closed the previous session at 5.40 yuan, down 0.55%. (Investing)

This is significant since the bank serves as a key indicator of how China’s major state lenders respond to changes in rates and credit demand. On the same day, two distinct forces come into play: targeted easing by the central bank and a crackdown on leveraged stock purchases.

Regulators are tightening controls as mainland stocks climb, with the Shanghai Composite close to a ten-year peak and trading volume reaching new highs. The directive is clear: dial down the risk but keep the market moving. (Reuters)

Margin trading is coming under pressure as investors borrow to buy shares. The Shanghai, Shenzhen, and Beijing stock exchanges announced they will raise the minimum margin ratio for leveraged purchases from 80% to 100%. They emphasized this applies only to new margin contracts, not those already open. (Shanghai Stock Exchange)

The People’s Bank of China announced it will trim rates on its “structural” policy tools by 25 basis points starting Jan. 19. The move targets sectors like small businesses, tech innovation, and green development. “It looks like the PBOC is deploying a combination of tools except an outright policy rate cut,” said Frances Cheung, head of FX and rate strategy at OCBC Bank. (Reuters)

Credit demand remains a persistent concern. In 2025, new bank loans in China hit 16.27 trillion yuan, marking the lowest level since 2018. December alone saw banks issue 910 billion yuan in fresh loans, according to Reuters calculations based on central bank data. Li Miaoxian, chief macroeconomic researcher at Jiangnan Rural Commercial Bank, noted, “New credit in 2025 was relatively weak for the year as a whole.” (Reuters)

For lenders like Bank of China, easing presents a tricky balance. Lower policy rates may boost lending in select areas, yet widespread cuts tend to compress net interest margins — the gap between loan yields and deposit costs.

The monthly Loan Prime Rate, a key benchmark for new loans, is up next. Market expectations point to stability, with the one-year LPR steady at 3.00% and the five-year holding at 3.50%, according to CME Group’s Econoday calendar. (CME Group)

Beyond China, risk appetite looks shaky. Reuters flagged that investors are gearing up for a “risk-off” mood as U.S. President Donald Trump threatened new tariffs on European goods, which could rattle markets come Monday’s open. (Reuters)

Bank of China typically moves alongside the other major state lenders — Industrial and Commercial Bank of China, China Construction Bank, and Agricultural Bank of China — since they face the same pressures on earnings: interest rates, credit expansion, and concerns over bad debts. When this group shifts, 601988 usually trails behind.

The downside scenario is straightforward. The tighter margin rule aims to rein in leverage and could drain some liquidity that’s been fueling short-term momentum. Meanwhile, stress in the property sector remains a slow-burning concern for lenders. China Vanke, one of the country’s top developers, is trying to extend grace periods on two onshore bonds. Bondholders are scheduled to vote between Jan. 21 and 26, according to Reuters. (Reuters)

Monday’s focus will be on whether Bank of China’s A shares hold steady now that the new policies are live — and if trading volume drops off with the 100% margin requirement in place. The next key event to watch is the LPR decision near Jan. 20, while Vanke’s bondholder votes later that week linger on the sidelines.

Stock Market Today

  • Medtronic advances into 2026 on diabetes spin-off, Hugo system, and steady dividends
    January 18, 2026, 4:43 PM EST. Medtronic (MDT) is trading on the prospect that a planned stand-alone spin-off of its diabetes business will sharpen focus on B2B operations and lift margins. Management has signaled the split should close by year-end 2026, reducing exposure to consumer diabetes care, which generated about 8% of revenue but only 4% of operating profit in fiscal 2025. A new growth driver comes from the Hugo robotic-assisted surgery (RAS) system, cleared in the U.S. for urologic procedures. While near-term top-line impact is modest, the device targets an underpenetrated market with long-term potential. Finally, Medtronic boasts a lengthy dividend streak, raising payouts for 48 consecutive years and offering about a 3% forward yield, with the potential to join the Dividend King club after 50 straight raises.
Thermo Fisher Scientific stock drops before long weekend as TMO traders brace for Jan. 29 earnings
Previous Story

Thermo Fisher Scientific stock drops before long weekend as TMO traders brace for Jan. 29 earnings

Intel stock price slides into earnings week: what INTC traders are watching now
Next Story

Intel stock price slides into earnings week: what INTC traders are watching now

Go toTop